Shell Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,797
| Closed | -$225K | – | 1379 |
|
|
2022
Q3 | $225K | Sell |
8,797
-2,306
| -21% | -$59K | 0.01% | 958 |
|
|
2022
Q2 | $315K | Buy |
11,103
+3,796
| +52% | +$108K | 0.01% | 956 |
|
|
2022
Q1 | $258K | Sell |
7,307
-1,099
| -13% | -$38.8K | 0.01% | 1097 |
|
|
2021
Q4 | $352K | Buy |
8,406
+61
| +0.7% | +$2.55K | 0.01% | 1048 |
|
|
2021
Q3 | $410K | Sell |
8,345
-360
| -4% | -$17.7K | 0.01% | 958 |
|
|
2021
Q2 | $363K | Buy |
+8,705
| New | +$363K | 0.01% | 1055 |
|